Medtronic Intrinsic
Value
As of 2024-12-13, the Intrinsic Value of Medtronic PLC (MDT) is
105.47 USD. This Medtronic valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 82.73 USD, the upside of Medtronic PLC is
27.50%.
The range of the Intrinsic Value is 66.77 - 216.96 USD
105.47 USD
Intrinsic Value
Medtronic Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
66.77 - 216.96 |
105.47 |
27.5% |
| DCF (Growth 10y) |
88.74 - 261.51 |
133.53 |
61.4% |
| DCF (EBITDA 5y) |
90.36 - 118.36 |
99.20 |
19.9% |
| DCF (EBITDA 10y) |
111.08 - 152.55 |
125.70 |
51.9% |
| Fair Value |
16.71 - 16.71 |
16.71 |
-79.80% |
| P/E |
109.95 - 141.39 |
127.00 |
53.5% |
| EV/EBITDA |
91.18 - 128.44 |
102.13 |
23.5% |
| EPV |
57.49 - 82.23 |
69.86 |
-15.6% |
| DDM - Stable |
33.64 - 111.87 |
72.76 |
-12.1% |
| DDM - Multi |
62.52 - 149.75 |
86.92 |
5.1% |
Medtronic Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
106,098.74 |
| Beta |
0.13 |
| Outstanding shares (mil) |
1,282.47 |
| Enterprise Value (mil) |
133,030.75 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.82% |
| Cost of Debt |
4.39% |
| WACC |
7.03% |